Search Results for 'immunotherapy'
-
Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery
Biothera, Genentech Enter Immunotherapy Clinical Trial Agreement
The collaboration will aim to treat patients with metastatic colorectal cancer11.28.17
-
Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development
AbbVie, Turnstone Biologics Enter Immunotherapy Agreement
Gains option to license three of Turnstone's next-gen oncolytic viral immunotherapies10.11.17
-
Drug Development | Industry News
Thermo Fisher Forms Cancer Immunotherapy Consortium
Aims to drive adoption of next-generation sequencing research to identify prognostic biomarkers08.31.17
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Drug Development | Industry News
Cell Medica Expands Immunotherapy Portfolio
Acquires WT1 cancer immunotherapy from Cell and Gene Therapy Catapult06.26.17
-
Biologics, Proteins, Vaccines
Will Immunotherapy Knock Out Cancer?
Innovative immunotherapy companies discuss with WuXi AppTec what’s next for this rapidly developing field ahead of BIO 2017.Online Exclusives06.14.17
-
Clinical Trials | Drug Development
Rethinking Immunotherapy Clinical Endpoints in Oncology Studies
Chris Smyth and Joy Yucaitis of Novella Clinical evaluate criteria, regulations, and limitationsChris Smyth, Ph.D. and Joy Yucaitis, Novella Clinical 10.28.16
-
Clinical Trials | Drug Development
Mastering Immunotherapy Clinical Trials: Dosing and Response
Andrew Zupnick of Novella Clinical provides insights into dosing and measuring response in immunotherapy clinical trialsOnline Exclusives Kristin Brooks, Contract Pharma 08.01.16
-
Clinical Trials | Drug Development
Mastering Immunotherapy Clinical Trials: Protocol Design
Andrew Zupnick of Novella Clinical discusses thorny questions about protocol design for immunotherapy clinical trialsOnline Exclusives Kristin Brooks, Contract Pharma 07.25.16
-
Breaking News | Collaborations & Alliances | Drug Discovery | Methods Development | R&D
MedImmune, Immunocore Enter Immunotherapy R&D Pact
Will utilize ImmTAC technology to develop cancer therapiesKristin Brooks 01.08.14
